ACB

ACB Earnings Preview

Aurora Cannabis Inc. · Healthcare · $205M

10d until earnings

ACB Earnings

Thursday, Jun 11 2026
Revenue Estimate
$75M
Current Price
$3.60

Our Position

neutral

Half of U.S. Adults Can Buy Cannabis Legally

est. revisions stable

Growing legal access and regulatory progress in the U.S. and Canada create a larger addressable market and support Aurora's medical-first strategy focusing on durable profitability.

Watch: Monitor U.S. federal reclassification progress as it could unlock broader market opportunities for Aurora's medical cannabis operations.

Data Signal Summary

0 bullish
1 bearish
Estimates down -387%

Key Context

Insider Activity
mixed
Price Trend
mixed
1-Month Return
+9.4%
From 52w High
-5.3%
Est. Revisions (30d)
-386.7% 0up/0dn
Analyst Target (mean)
$6 $6–$6 +76%
Options P/C Ratio
1.10
Est. Dispersion
126% 3 analysts
Fund Convergence
strong Citadel, Renaissance, Two Sigma